IfPA’s Patient Access Policy Blog

Cardiac Meds Cut Patients’ Heart Attack Risk – Or Your Money Back

Cholesterol-lowering drugs known as PCSK9 inhibitors can reduce the risk of heart, stroke and cardiovascular death by 20 percent, new research confirms.  And if patients

Read More

How a Human Milk Diet Protects Premature Infants

“Breast is best” is familiar advice for new mothers and infant health care providers.  But what about mothers of preemies, who often struggle to produce

Read More

Poor & Black Children Bear the Brunt of Asthma, Research Confirms

More than 6 million children in the United States suffer from asthma. But several new studies paint a startling picture of how this disease impacts

Read More

“Death Panel” Trigger Could Limit Medicare Access

Once dubbed a “death panel”, the Independent Payment Advisory Board is back in the news. The board was devised under the Affordable Care Act as

Read More

HHS Reports Tout Value of Hepatitis C Treatment, Screening

Two new publications point to the value of treating hepatitis C – early, aggressively and alongside heightened screening efforts. Expert Consultation Report The Department of

Read More

New Opioid Guidelines, Same Coverage Quandry

New pain treatment guidelines underscore a now familiar disconnect: the gap between what patients need and what their health plans will pay for. The American

Read More

Rare Disease Day Spotlights Need for Research

Rare Disease Day brings international attention to the plight of patients who struggle with ALS, Gaucher disease, cystic fibrosis and other less common conditions.  This

Read More

New Cystic Fibrosis Group Weighs in on Obamacare Revamp

As Congress continues to debate the future of the Affordable Care Act, a new advocacy group has a message for key legislators: protect cystic fibrosis

Read More

Does ICER Model Work for Rheumatoid Arthritis Treatments?

The Institute for Clinical and Economic Review’s newest cost-effectiveness report underscores just how far economic modeling sometimes diverges from patients’ reality, explained the Institute for

Read More

Fewer Treatment Choices and Higher Costs Plague Diabetes Patients

Access to medication has become an all-too-common challenge for patients with one of the country’s most common diseases: diabetes. Several health plans announced in late

Read More
Back to Top